fotemustine has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitini, E; Ballardini, M; Bichisao, E; Fiorentini, G; Freschi, A; Guida, M; Michiara, M; Ridolfi, L; Ridolfi, R | 1 |
| Beauchesne, PD; Bernier, V; Carnin, C; Taillandier, L | 1 |
| Ferri-Níguez, B; González-Tortosa, J; Ros de San Pedro, J | 1 |
| Bensadoun, RJ; Bonneterre, ME; Bourdin, S; Bui, BN; Clavel, M; Cupissol, D; De Gislain, C; Delaunay, MM; Guillot, B; Hauschild, A; Lesimple, T; Mohr, P; Mornex, F; Mousseau, M; Thomas, L; Tilgen, W; Ulrich, J | 1 |
| Dieckmann, K; Fazeny-Dörner, B; Hainfellner, J; Marosi, C; Piribauer, M; Rössler, K; Ungersböck, K; Veitl, M; Wenzel, C | 1 |
| Bensadoun, JR; Bonneterre, J; Bourdin, S; Clavel, M; Cupissol, D; de Gislain, C; Delaunay, MM; Guillot, B; Hauschild, A; Lesimple, T; Mohr, P; Mornex, F; Mousseau, M; Nguyen, BB; Thomas, L; Tilgen, W; Ulrich, J | 1 |
| Ardiet, C; Berger, E; Bouafia, F; Coiffier, B; Dumontet, C; Guyotat, D; Jaubert, J; Lucas, C; Sebban, C; Tranchand, B | 1 |
| Eigentler, TK; Garbe, C | 1 |
| Karpenko, LG | 1 |
2 review(s) available for fotemustine and Disease Exacerbation
| Article | Year |
|---|---|
[Cerebellopontine angle meningeal melanocytoma: a benign tumor?].
Topics: Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellopontine Angle; Diagnosis, Differential; Disease Progression; Fatal Outcome; Gait Disorders, Neurologic; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Melanocytes; Melanoma; Meningeal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neurilemmoma; Nevus; Nitrosourea Compounds; Organophosphorus Compounds | 2009 |
[Therapy of malignant melanoma at the stage of distant metastasis].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine | 2004 |
6 trial(s) available for fotemustine and Disease Exacerbation
| Article | Year |
|---|---|
Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Humans; Immunologic Factors; Immunotherapy; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Salvage Therapy; Skin Neoplasms; Survival Analysis | 2009 |
Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Glioma; Hematologic Diseases; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Stereotaxic Techniques; Supratentorial Neoplasms; Survival Rate | 2009 |
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Skin Neoplasms; Survival Rate; Treatment Outcome | 2003 |
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.
Topics: Adolescent; Adult; Aged; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Analysis; Survival Rate | 2003 |
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma].
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Female; Humans; Life Tables; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients.
Topics: Aged; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Outpatients; Prognosis; Recurrence; Sepsis; Thrombocytopenia | 2003 |
1 other study(ies) available for fotemustine and Disease Exacerbation
| Article | Year |
|---|---|
[Experience with use of mustoforan at the Clinical Oncological Dispensary of the Republic of Tatarstan].
Topics: Antineoplastic Agents; Cancer Care Facilities; Disease Progression; Humans; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Russia; Skin Neoplasms; Treatment Outcome | 2005 |